XRCC1 protects against particulate chromate-induced chromosome damage and cytotoxicity in Chinese hamster ovary cells

被引:5
作者
Grlickova-Duzevik, Eliza [1 ]
Wise, Sandra S. [1 ]
Munroe, Ray C. [1 ]
Thompson, W. Douglas [1 ]
Wise, John Pierce, Sr. [1 ]
机构
[1] Univ So Maine, Maine Ctr Toxicol & Environm Hlth, Wise Lab Environm & Genet Toxicol, Portland, ME 04104 USA
关键词
chromate; particulate; XRCC1; chromosome instability; single-strand breaks;
D O I
10.1093/toxsci/kfj183
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Water-insoluble hexavalent chromium compounds are well-established human lung carcinogens. Lead chromate, a model insoluble Cr(VI) compound, induces DNA damage, chromosome aberrations, and dose-dependent cell death in human and Chinese hamster ovary (CHO) cells. The relationship between lead chromate-induced DNA damage and chromosome aberrations is unknown. Our study focus was on examining the role of XRCC1 in lead chromate-induced cytotoxicity and structural chromosomal aberrations in CHO cells. Three different cell lines were used: AA8 (parental), EM9 (XRCC1 mutant), and H9T3 (EM9 complemented with human XRCC1 gene). Cytotoxicity was significantly higher in EM9 cells when compared to AA8 and H9T3 cells, indicating that XRCC1 is important for protecting cells from lead chromate particles-induced cell death. The frequency of damaged metaphase cells was not affected by XRCC1 deficiency. However, the total amount of Cr(VI)-induced chromosome damage was exacerbated by XRCC1 deficiency, and the spectrum of damage changed dramatically. Chromatid and isochromatid lesions were the most prominent aberrations induced in all cell lines. XRCC1 was essential to reduce the formation of chromatid lesions, but not for isochromatid lesions. In addition, XRCC1 deficiency resulted in a dramatic increase in the number of chromatid exchanges, indicating that XRCC1 is involved in protection from lead chromate-induced chromosome instability.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 40 条
  • [1] [Anonymous], 1990, IARC MON EV CARC RIS
  • [2] BIANCHI U, 1980, CELL DIFFER, V6, P323
  • [3] XRCC1 and DNA strand break repair
    Caldecott, KW
    [J]. DNA REPAIR, 2003, 2 (09) : 955 - 969
  • [4] USE OF MAMMALIAN DNA REPAIR-DEFICIENT MUTANTS TO ASSESS THE EFFECTS OF TOXIC METAL-COMPOUNDS ON DNA
    CHRISTIE, NT
    CANTONI, O
    EVANS, RM
    MEYN, RE
    COSTA, M
    [J]. BIOCHEMICAL PHARMACOLOGY, 1984, 33 (10) : 1661 - 1670
  • [5] ONCOGENIC CONVERSION OF TRANSCRIPTION FACTORS BY CHROMOSOMAL TRANSLOCATIONS
    CLEARY, ML
    [J]. CELL, 1991, 66 (04) : 619 - 622
  • [6] CROCE CM, 1986, CANCER RES, V46, P6019
  • [7] METABOLIC REDUCTION OF CHROMIUM, AS RELATED TO ITS CARCINOGENIC PROPERTIES
    DEFLORA, S
    SERRA, D
    CAMOIRANO, A
    ZANACCHI, P
    [J]. BIOLOGICAL TRACE ELEMENT RESEARCH, 1989, 21 : 179 - 187
  • [8] GENOTOXICITY OF CHROMIUM COMPOUNDS - A REVIEW
    DEFLORA, S
    BAGNASCO, M
    SERRA, D
    ZANACCHI, P
    [J]. MUTATION RESEARCH, 1990, 238 (02): : 99 - 172
  • [9] Defective DNA strand break repair after DNA damage in prostate cancer cells: Implications for genetic instability and prostate cancer progression
    Fan, R
    Kumaravel, TS
    Jalali, F
    Marrano, P
    Squire, JA
    Bristow, RG
    [J]. CANCER RESEARCH, 2004, 64 (23) : 8526 - 8533
  • [10] Frequent microsatellite instability in lung cancer from chromate-exposed workers
    Hirose, T
    Kondo, K
    Takahashi, Y
    Ishikura, H
    Fujino, H
    Tsuyuguchi, M
    Hashimoto, M
    Yokose, T
    Mukai, K
    Kodama, T
    Monden, Y
    [J]. MOLECULAR CARCINOGENESIS, 2002, 33 (03) : 172 - 180